Dare Bioscience, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.12
|
-0.08
|
0.04
|
33.33%
|
|
2022-06-30
|
-0.06
|
0.00
|
0.06
|
108.00%
|
|
2022-03-31
|
-0.14
|
-0.10
|
0.04
|
28.57%
|
|
2021-12-31
|
-0.15
|
-0.18
|
-0.03
|
-20.00%
|
|
2021-09-30
|
-0.13
|
-0.18
|
-0.05
|
-38.46%
|
|
2021-06-30
|
-0.16
|
-0.18
|
-0.02
|
-12.50%
|
|
2021-03-31
|
-0.22
|
-0.16
|
0.06
|
27.27%
|
|
2020-12-31
|
-0.13
|
-0.28
|
-0.15
|
-115.38%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.18
|
|
2021-12-31
|
-0.70
|
|
2020-12-31
|
-0.97
|
|
2019-12-31
|
-0.97
|
|
2018-12-31
|
-1.68
|
|
2017-12-31
|
-4.71
|
|
2016-12-31
|
-14.10
|
|
2015-12-31
|
-5.07
|
|
2014-12-31
|
-40.52
|